More Articles
A prevalence of left atrial fibrosis in endurance athletes could explain their increased risk for arrhythmias like atrial fibrillation (AFib), according to data presented this week at the European Society of Cardiology (ESC) Congress in Munich.…
Combining oral anticoagulants with antiplatelet therapy in atrial fibrillation patients could be more than just overkill, University of Edinburgh researchers reported at the European Society of Cardiology (ESC)’s annual meeting this month—it…
More than 40 percent of patients with atrial fibrillation (AFib) but no record of stroke or transient ischemic attack have previously unknown, “silent” brain damage, according to…
A new study published in the American Journal of Cardiology suggests women aged 45 and older who experienced traumatic life events could have a 37 percent…
A handheld cardiac rhythm recorder that links to a smartphone application detected atrial fibrillation (AFib) with 96.6 percent sensitivity and 94.1 percent specificity compared to physician-interpreted electrocardiograms (ECGs), according…
More than 100,000 individuals across the nation learned about hands-only CPR through training kiosks since the American Heart Association (AHA), along with Anthem Foundation, launched its program in 2016.
Currently, 30 hands-only CPR…
Chagas disease—the result of infection with a parasite called Trypanosoma cruzi…
The factor Xa inhibitor edoxaban might reduce the risk of several adverse events—including stroke, major bleeding and all-cause death—when compared to warfarin, according to a real-world …
Japanese researchers believe they’ve identified a genetic risk marker that could pinpoint which people with atrial fibrillation (AFib) are at risk of developing tachycardia-induced cardiomyopathy (TIC).
“[TIC] is a…
A screening program for top teen soccer players in England identified heart disorders associated with sudden cardiac death in one out of every 266 individuals. But among the eight athletes who eventually died of sudden cardiac arrest, six…
Medtronic has launched the pilot study of its extravascular implantable cardioverter defibrillator (EV ICD), which is designed to deliver defibrillation and antitachycardia pacing without transvenous leads. Instead, the leads are placed…
Atrial fibrillation (AFib) and atrial flutter (AFL) are often regarded as interchangeable when informing the management of stroke risk. However, a new study…
A New Jersey cardiologist specializing in electrophysiology was sentenced July 31 to 20 months in prison for billing the Veterans Affairs (VA) program hundreds of thousands of dollars for services he never performed.
…
A calcium-channel blocker delivered as a nasal spray rapidly restored individuals with paroxysmal supraventricular tachycardia (SVT) to normal sinus rhythm in a phase 2 study, raising…
Epinephrine doses administered by paramedics significantly improved the odds of 30-day survival for patients following out-of-hospital cardiac arrest (OHCA), according to a randomized, placebo-controlled trial published in the…
Asthma and uncontrolled asthma are associated with a 38 percent increased risk of developing atrial fibrillation (AFib), according to new research published in…
Non-vitamin K antagonist oral anticoagulants may be even more effective for treating women with atrial fibrillation (AFib) than men, suggests a real-world study from Hong Kong published in the …
The more a person smokes, the greater the risk of developing a heart rhythm disorder, according to a new study published July 11 in the European Journal of…
Blacks who survive in-hospital cardiac arrest (IHCA) are 28 percent less likely to live to one year after discharge and 33 percent less likely to survive five years when compared to white counterparts, suggesting a disparity in follow-up…
Nonsteroidal anti-inflammatory drugs (NSAIDs) can be dangerous for patients with atrial fibrillation (AFib) when taken on top of oral anticoagulants, suggests a post hoc analysis of the RE-…
Boston Scientific plans to acquire Cryterion Medical, a company developing a single-shot cryoablation platform to treat patients with atrial fibrillation (AFib). Already an investor in the company, Boston Scientific will purchase the…